- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
States' Medicaid Decisions Cost Community Health Centers
Community health centers will pay a steep price for states' decisions not to expand Medicaid under the federal health law.
Community health centers will pay a steep price for states’ decisions not to expand Medicaid under the federal health law.
A new study by George Washington University researchers estimates that 518 health centers in the more than two dozen states not expanding Medicaid will lose out on $555 million next year because their uninsured patients won’t get Medicaid or federally subsidized coverage in the new online health insurance marketplaces.
“That is huge,” said Peter Shin, lead author of the study and associate professor of health policy at George Washington University. He said loss of money can affect centers’ ability to hire doctors and other staff, as well as to expand services. He said health centers expect increased patient demand regardless of whether their state expands Medicaid.
The 582 health centers in states expanding Medicaid can expect to gain about $2 billion in funding next year from seeing more patients in line to get coverage, the study said.
Read the full story here: http://bit.ly/1gKK3pE
Source: Kaiser Health News
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
